Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Deferasirox in sickle cell disease with iron overload
NCT00110617Phase 2Completed
- Sponsor
- Novartis
- Start
- May 2005
- Primary completion
- Apr 2008
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 2 trial of deferasirox in iron overload, sponsored by Novartis. Started May 2005; status: completed.
02
Drugs
deferasirox
03
Conditions
iron overload
Beyond the preview
Go deeper on NCT00110617.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00110617.